[HTML][HTML] Update on global epidemiology of viral hepatitis and preventive strategies
M Jefferies, B Rauff, H Rashid, T Lam… - World journal of clinical …, 2018 - ncbi.nlm.nih.gov
Viral hepatitis is one of the major public health concerns around the world but until recently it
has drawn little attention or funding from global health policymakers. Every year 1.4 million …
has drawn little attention or funding from global health policymakers. Every year 1.4 million …
A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug …
A Radley, E Robinson, EJ Aspinall, K Angus… - BMC health services …, 2019 - Springer
Abstract Background Direct Acting Antiviral (DAAs) drugs have a much lower burden of
treatment and monitoring requirements than regimens containing interferon and ribavirin …
treatment and monitoring requirements than regimens containing interferon and ribavirin …
[图书][B] Best practices in child and adolescent tuberculosis care
World Health Organization - 2018 - apps.who.int
The global tuberculosis (TB) and child health community has increasingly prioritized the
childhood TB epidemic. In 2013, the childhood TB subgroup developed and published the …
childhood TB epidemic. In 2013, the childhood TB subgroup developed and published the …
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Abstract Background and Aims People who have recently injected drugs are a priority
population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the …
population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the …
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort
Background & Aims Direct-acting antiviral therapies (DAA) are an important tool for hepatitis
C virus (HCV) elimination. However, reinfection among people who inject drugs (PWID) may …
C virus (HCV) elimination. However, reinfection among people who inject drugs (PWID) may …
[HTML][HTML] 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
ML Yu, PJ Chen, CY Dai, TH Hu, CF Huang… - Journal of the Formosan …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …
Hepatitis B: current status of therapy and future therapies
E Spyrou, CI Smith, MG Ghany - Gastroenterology Clinics, 2020 - gastro.theclinics.com
Chronic hepatitis B virus (HBV) infection is a substantial global public health problem.
Despite the availability of a protective vaccine for more than 3 decades, the prevalence of …
Despite the availability of a protective vaccine for more than 3 decades, the prevalence of …
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia
Background Uptake of hepatitis C virus (HCV) testing remains inadequate globally.
Simplified point-of-care tests should enhance HCV diagnosis and elimination. We aimed to …
Simplified point-of-care tests should enhance HCV diagnosis and elimination. We aimed to …
[HTML][HTML] HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
S Lens, A Miralpeix, M Gálvez, E Martró, N González… - JHEP Reports, 2022 - Elsevier
Background & Aims Significant scale-up of treatment among people who inject drugs (PWID)
is crucial to achieve WHO HCV elimination targets. We explored the impact of on-site HCV …
is crucial to achieve WHO HCV elimination targets. We explored the impact of on-site HCV …
“Treated like a Human Being”: perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City
SN Kapadia, Y Aponte-Melendez, A Rodriguez… - Harm Reduction …, 2023 - Springer
Abstract Background Hepatitis C virus (HCV) treatment can effectively cure HCV among
people who inject drugs (PWID). Perspectives of PWID treated in innovative models can …
people who inject drugs (PWID). Perspectives of PWID treated in innovative models can …